125 related articles for article (PubMed ID: 6792644)
1. Investigation of the mechanism of action of prostaglandin synthesis inhibitors on renin and aldosterone secretion and sodium excretion.
Papanicolaou N; Papadakis G; Papanicolaou P; Theodorakopoulos P; Paris M; Dontas A; Paris M; Bariety J; Milliez P
Prostaglandins Med; 1981 Aug; 7(2):163-81. PubMed ID: 6792644
[TBL] [Abstract][Full Text] [Related]
2. Is low urinary prostaglandin concentration a stage in the development of essential hypertension?
Papanicolaou N; Safar M; Tsapara-Stavroulaki A; Baskiotis C; Lefkos N; Paris M; Marketos S; Bariéty J; Dontas A; Milliez P
Prostaglandins Med; 1979 Jul; 3(1):53-67. PubMed ID: 399528
[TBL] [Abstract][Full Text] [Related]
3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
4. Suppression of plasma renin activity by indomethacin in man.
Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
[TBL] [Abstract][Full Text] [Related]
5. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
Ruilope L; Garcia Robles R; Barrientos A; Bernis C; Alcazar J; Tresguerres JA; Mancheño E; Millet VG; Sancho J; Rodicio JL
Clin Exp Hypertens A; 1982; 4(6):989-1000. PubMed ID: 7047008
[TBL] [Abstract][Full Text] [Related]
6. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
[TBL] [Abstract][Full Text] [Related]
7. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
[TBL] [Abstract][Full Text] [Related]
8. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
[No Abstract] [Full Text] [Related]
9. Dissociation of renin--aldosterone and renal prostaglandin E during volume expansion induced by immersion in normal man.
Epstein M; Lifschitz MD; Re R; Haber E
Clin Sci (Lond); 1980 Jul; 59(1):55-62. PubMed ID: 7009025
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin blockade of renal PGE-synthesis: effect on total renal and tubular function and plasma renin concentration in hydropenic rats and on their response to isotonic saline.
Leyssac PP; Christensen P; Hill R; Skinner SL
Acta Physiol Scand; 1975 Aug; 94(4):484-96. PubMed ID: 1180089
[TBL] [Abstract][Full Text] [Related]
11. Effects of indomethacin on the renal function and renin-aldosterone system in chronic glomerulonephritis.
Kutyrina IM; Androsova SO; Warshavskii VA; Tareyeva IE
Nephron; 1982; 32(3):244-8. PubMed ID: 6759952
[TBL] [Abstract][Full Text] [Related]
12. Role of renal prostaglandin E2 in chronic renal disease hypertension.
Ruilope L; Garcia Robles P; Bernis C; Barrientos A; Alcazar J; Tresguerres JA; Sancho J; Rodicio JL
Nephron; 1982; 32(3):202-6. PubMed ID: 6759949
[TBL] [Abstract][Full Text] [Related]
13. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
[TBL] [Abstract][Full Text] [Related]
14. Urinary prostaglandin and sodium metabolism in patients with essential hypertension.
Yasujima N; Abe K; Irokawa N; Chiba S; Sato M; Seino M; Sakurai Y; Saito K; Ito T; Ritsu K; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):277-83. PubMed ID: 635902
[TBL] [Abstract][Full Text] [Related]
15. Humoral determinants of Na+ excretion after intravenous NaCl loading in normal volunteers.
Stokes GS; Johnston HJ; Monaghan JC
Clin Exp Pharmacol Physiol; 1993 May; 20(5):310-2. PubMed ID: 8324915
[TBL] [Abstract][Full Text] [Related]
16. Role of hypervolemia and renin in the blood pressure control of patients with pyelonephritis renal scarring.
Jacobson SH; Kjellstrand CM; Lins LE
Acta Med Scand; 1988; 224(1):47-53. PubMed ID: 3046233
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic infusion of atrial natriuretic factor on plasma and urinary aldosterone, plasma renin activity, blood pressure and sodium excretion in 2-K, 1-C hypertensive rats.
Garcia R; Thibault G; Gutkowska J; Cantin M
Clin Exp Hypertens A; 1986; 8(7):1127-47. PubMed ID: 2945679
[TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandins in the control of renin secretion in the dog.
Yun J; Kelly G; Bartter FC; Smith H
Circ Res; 1977 May; 40(5):459-64. PubMed ID: 852103
[TBL] [Abstract][Full Text] [Related]
19. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
